Triaminic Vapor Patch, a medicated cough-suppressant patch for children, is being recalled after a young child suffered a seizure from chewing on the product.
Drug manufacturer, Novartis AG, will voluntarily pull the patch off the market due to the adverse effects in children who may possibly ingest the medication.
According to the company, at least eight cases of bad reactions involving children accidentally ingesting the patch have been reported so far, including the child who had a seizure.
Triaminic Vapor patch comes in mentholated cherry and menthol scented version that are designed to alleviate flu-like symptoms such as a soar throat and cough. The patch is supposed to be placed on the chest or throat of children to allow the medicated vapors to reach the mouth and nose.
However, the required placement of the product makes it too simple for children to remove it and chew or ingest the patch.
Other negative side effects that may occur from ingesting the patch include a burning feeling in the mouth, nausea, vomiting, seizure, and headache.
Novartis urges all consumers to immediately stop using the patch, which is sold over the counter. Since its release, the company has sold over 50 million patches in the U.S.
